Gestational Diabetes Mellitus (GDM) and Autism Risk in Offspring: A Systematic Review and Meta-Analysis

Main Article Content

Laksmy Dewi Sukmakarti
Arif Siswanto

Abstract

Background: Autism spectrum disorder (ASD) affects social communication and reciprocal interaction abilities in children. Maternal diabetes mellitus during pregnancy, specifically gestational diabetes mellitus (GDM), represents a potentially modifiable risk factor associated with elevated ASD risk in offspring. The aim of this study was to assess the relationship between diabetes in mothers and the risk of autism spectrum disorder (ASD) in children through a systematic review and meta-analysis.

Methods: This research is a systematic review and meta-analysis of nine cohort studies involving diverse populations to evaluate the association between mothers with diabetes during pregnancy and the risk of ASD in their offspring (2015–2024) sourced from PubMed, Google Scholar, and ScienceDirect. A random-effects model was used to calculate adjusted odds ratios (aOR).

Results: Data from 3,908,133 children showed that maternal diabetes increases the ASD risk by 16% (aOR = 1.16, 95% CI: 1.11–1.22, p<0.001), with significant heterogeneity (I² = 79%). 

Conclusion: This meta-analysis identified a statistically significant but modest association between maternal diabetes mellitus during pregnancy and ASD risk in offspring. The relationship reflects an observational association and cannot establish causality. These findings emphasize the clinical importance of preconception glycemic optimization, enhanced antenatal monitoring of maternal glucose control, and developmental surveillance of offspring born to diabetic mothers.

Article Details

How to Cite
Gestational Diabetes Mellitus (GDM) and Autism Risk in Offspring: A Systematic Review and Meta-Analysis. (2025). Jurnal Keterapian Fisik, 10(2), 80-94. https://doi.org/10.37341/jkf.v10i2.461
Section
Articles

How to Cite

Gestational Diabetes Mellitus (GDM) and Autism Risk in Offspring: A Systematic Review and Meta-Analysis. (2025). Jurnal Keterapian Fisik, 10(2), 80-94. https://doi.org/10.37341/jkf.v10i2.461

References

Alves, J. M., Angelo, B. C., Negriff, S., Luo, S. H., Chow, T., Cabeen, R., Carter, S. A., Xiang, A., & Page, K. A. (2022). Prenatal exposure to gestational diabetes mellitus and autistic traits among typically developing children. Diabetes, 71(Supplement 1), 602-P. https://doi.org/10.2337/db22-602-P

American Diabetes Association. (2021). Standards of medical care in diabetes—2021. Diabetes Care, 44(Supplement 1), S1–S2. https://doi.org/10.2337/dc21-sint

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.

Carter, S. A., Lin, J. C., Chow, T., Yu, X., Rahman, M. M., Martinez, M. P., Feldman, K., Eckel, S. P., Chen, J. C., Chen, Z., Levitt, P., Lurmann, F. W., McConnell, R., & Xiang, A. H. (2022). Maternal obesity, diabetes, preeclampsia, and asthma during pregnancy and likelihood of autism spectrum disorder with gastrointestinal disturbances in offspring. Autism, 26(8), 1950–1962. https://doi.org/10.1177/13623613221118430

Chang, J. S., Chou, L. H., Hsieh, W. S., Chen, W. J., & Chen, C. J. (2023). Gestational diabetes mellitus and the risk of autism spectrum disorder in Taiwan. Journal of Developmental & Behavioral Pediatrics, 44(6), 371–378.

Chen, Q., Sjölander, A., Håberg, S. E., Sørensen, T. I. A., & Almqvist, C. (2022). Maternal diabetes and the risk of autism spectrum disorder among children born after 1990 in Sweden: A population-based study. European Journal of Epidemiology, 37, 181–189.

Cordero, M. E., D'Acuña, G., Kanterewicz, B., Contreras, P., & Valenzuela, R. (2019). Maternal diabetes: Fetal consequences. Placenta, 11(4), 363–378.

Etminan-Baksh, M., Tadi, S., Hatami, M., & Darabi, R. (2020). Prevalence of gestational diabetes mellitus and its associated risk factors in Boo-Ali Hospital, Tehran. Galen Medical Journal, 9(0), e1642. https://doi.org/10.31661/gmj.v9i0.1642

Hilde-Gorman, E., Susi, A., Stokes, T., Gorman, G., Erdie-Lalena, C., & Nylund, C. M. (2018). Prenatal, perinatal, and neonatal risk factors of autism spectrum disorder. Pediatric Research, 84(2), 190–198. https://doi.org/10.1038/pr.2018.23

Katz, J., Reichenberg, A., & Kolevzon, A. (2021). Prenatal and perinatal metabolic risk factors for autism: a review and integration of findings from population-based studies. Current opinion in psychiatry, 34(2), 94–104. https://doi.org/10.1097/YCO.0000000000000673

Lachnospiraceae-derived butyrate mediates protection of high fermentable fiber against placental inflammation in gestational diabetes mellitus. (2023). Science Advances, 9(44), eadi7337. https://doi.org/10.1126/sciadv.adi7337

Li, Y., Ren, X., He, L., Li, J., Zhang, S., & Chen, W. (2020). Maternal age and the risk of gestational diabetes mellitus: A systematic review and meta-analysis of over 120 million participants. Diabetes Research and Clinical Practice, 162, 108044. https://doi.org/10.1016/j.diabres.2020.108044

Liu, J., Wei, Y., & Meng, W. (2023). Gestational diabetes mellitus and autism spectrum disorder risk in Chinese children. Chinese Medical Journal, 136(15), 1832–1839.

Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K., & Bishop, S. L. (2012). Autism diagnostic observation schedule–2nd edition (ADOS-2). Western Psychological Services.

Lu, J., Wang, Z., Liang, Y., & Yao, P. (2022). Rethinking autism: The impact of maternal risk factors on autism development. American Journal of Translational Research, 14(2), 1136–1145.

Maenner, M. J., Shaw, K. A., Bakian, A. V., Bilder, D. A., Durkin, M. S., Esler, A., Furnier, S. M., Hallas, L., Hall-Lande, J., Hudson, A., Hughes, M. M., Patrick, M., Pierce, K., Poynter, J. N., Salinas, A., Shenouda, J., Vehorn, A., Warren, Z., Constantino, J. N., & Cogswell, M. E. (2021). Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018. MMWR Surveillance Summaries, 70(11), 1–16. https://doi.org/10.15585/mmwr.ss7011a1

Márquez-Valadez, B., Flores-García, A., Morfin-Otero, R., Espinosa-de los Monteros, L. E., & Flores-Figueroa, E. (2018). Maternal diabetes and fetal programming toward neurological diseases. Frontiers in Endocrinology, 9, 664. https://doi.org/10.3389/fendo.2018.00664

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., & Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n160. https://doi.org/10.1136/bmj.n71

Pan, Y., & Wan, Z. (2018). Maternal diabetes induces autism-like behavior by hyperglycemia-mediated persistent oxidative stress and suppression of superoxide dismutase 2. Proceedings of the National Academy of Sciences, 116(47), 23743–23748. https://doi.org/10.1073/pnas.1918284116

Rowland, D. (2020). The neurophysiological cause of autism. Journal of Neurology & Neurophysiology, 11(5), 576.

Wan, H., Zhang, C., Li, H., Luan, S., & Liu, C. (2018). Association of maternal diabetes with autism spectrum disorders in offspring. Medicine (United States), 97(2). https://doi.org/10.1097/MD.0000000000009438

Waterhouse, L. (2022). Heterogeneity thwarts autism explanatory power: A proposal for endophenotypes. Frontiers in Psychiatry, 13, 947653. https://doi.org/10.3389/fpsyt.2022.947653

Xu, G., Strathearn, L., Liu, B., Yang, B., & Bao, W. (2018). Maternal diabetes and the risk of autism spectrum disorders in the offspring: A systematic review and meta-analysis. Journal of Autism and Developmental Disorders, 48(12), 3913–3927. https://doi.org/10.1007/s10803-018-3657-z

Zhu, B., Deng, F., Yan, S., Huang, K., Wu, X., Tao, X., Wang, S., & Tao, F. (2021). Gestational diabetes mellitus, autistic traits and ADHD symptoms in toddlers: Placental inflammatory and oxidative stress cytokines do not play an intermediary role. Psychoneuroendocrinology, 134, 105435. https://doi.org/10.1016/j.psyneuen.2021.105435